http://www.fierceemr.com/story/fda-wants-use-emrs-streamline-adverse-drug-event-reporting/2014-01-08 Kind regards, Julien Julien de Salaberry M: +65 9488 7334 E: desalaberry@propellgroup.biz propell.restartacademy.co Skype: propell_jdes Send from my iPad